Lavipharm S.A Strategic Asset Allocation Index
Lavipharm S.A strategic asset allocation index. Lavipharm S.A (LAVI) has a Strategic Asset Allocation Index of 40.4% as of June 2023. Strategic assets (PP&E of €17.20 Million plus long-term investments of €-) total €17.20 Million, measured against net assets of €42.53 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Lavipharm S.A (LAVI) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lavipharm S.A (2022–2022)
Strategic asset allocation index of Lavipharm S.A from 2022 to 2022. This chart shows how Lavipharm S.A's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of June 2023, the index stands at 40.4%, representing strategic assets of €17.20 Million against net assets of €42.53 Million EUR.
Lavipharm S.A Strategic Asset Allocation Index by Year (2022–2022)
Lavipharm S.A strategic asset allocation index by year from 2022 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Lavipharm S.A from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lavipharm S.A (LAVI) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.3% | €17.06 Million | €17.06 Million | €- | €40.28 Million | — |